Research Paper Volume 12, Issue 19 pp 19546—19562

Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects

class="figure-viewer-img"

Effects of iPSCs/MSCs-Exos on the cell cycle. (A)HCECs were treated with iPSCs/MSCs-Exos. Then, after 24 h, the distribution of cell cycle was determined by flow cytometry. (B) The cell number in each stage was quantified and is shown in the bar graphs. iPSCs-Exos significantly increased the number of HCECs in the S phase, which was accompanied by a significant decrease in the number of cells in the G0/G1 phase. (C) After HCECs were stimulated with iPSCs/MSCs-Exos for 48 h, immunofluorescent staining was performed with anti-Ki-67 antibody. The nuclei were stained by DAPI. (D) Quantitative RT-PCR analysis of HCECs showed that PCNA, cyclin A and CDK2 mRNA were upregulated in iPSCs-Exos group compared with MSCs-Exos group and the control. (E) Protein levels of PCNA, cyclin A and CDK2 were measured by western-blot after treatment with iPSCs/MSCs-Exos for 24 h. The data shown here are the mean ± SEM from three independent experiments. * P<0.05, ** P<0.01.